144 related articles for article (PubMed ID: 10954596)
1. Loss of drug-stimulated topoisomerase II DNA breaks in living cells is different at two unrelated loci.
Binaschi M; Borgnetto ME; Capranico G
Nucleic Acids Res; 2000 Sep; 28(17):3289-93. PubMed ID: 10954596
[TBL] [Abstract][Full Text] [Related]
2. Drug-specific sites of topoisomerase II DNA cleavage in Drosophila chromatin: heterogeneous localization and reversibility.
Borgnetto ME; Zunino F; Tinelli S; Kas E; Capranico G
Cancer Res; 1996 Apr; 56(8):1855-62. PubMed ID: 8620504
[TBL] [Abstract][Full Text] [Related]
3. In vivo localization of DNA topoisomerase II cleavage sites on Drosophila heat shock chromatin.
Rowe TC; Wang JC; Liu LF
Mol Cell Biol; 1986 Apr; 6(4):985-92. PubMed ID: 3023886
[TBL] [Abstract][Full Text] [Related]
4. Genomic sites of topoisomerase II activity determined by comparing DNA breakage enhanced by three distinct poisons.
Borgnetto ME; Tinelli S; Carminati L; Capranico G
J Mol Biol; 1999 Jan; 285(2):545-54. PubMed ID: 9878428
[TBL] [Abstract][Full Text] [Related]
5. Bioflavonoids cause DNA double-strand breaks and chromosomal translocations through topoisomerase II-dependent and -independent mechanisms.
Goodenow D; Emmanuel F; Berman C; Sahyouni M; Richardson C
Mutat Res Genet Toxicol Environ Mutagen; 2020 Jan; 849():503144. PubMed ID: 32087851
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase II cleavage in chromatin.
Udvardy A; Schedl P; Sander M; Hsieh TS
J Mol Biol; 1986 Sep; 191(2):231-46. PubMed ID: 3027349
[TBL] [Abstract][Full Text] [Related]
7. In vivo topoisomerase II cleavage of the Drosophila histone and satellite III repeats: DNA sequence and structural characteristics.
Käs E; Laemmli UK
EMBO J; 1992 Feb; 11(2):705-16. PubMed ID: 1311255
[TBL] [Abstract][Full Text] [Related]
8. Suppressing proteasome mediated processing of topoisomerase II DNA-protein complexes preserves genome integrity.
Sciascia N; Wu W; Zong D; Sun Y; Wong N; John S; Wangsa D; Ried T; Bunting SF; Pommier Y; Nussenzweig A
Elife; 2020 Feb; 9():. PubMed ID: 32057297
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide-resolution mapping of topoisomerase-mediated and apoptotic DNA strand scissions at or near an MLL translocation hotspot.
Mirault ME; Boucher P; Tremblay A
Am J Hum Genet; 2006 Nov; 79(5):779-91. PubMed ID: 17033956
[TBL] [Abstract][Full Text] [Related]
10. Double-stranded DNA cleavage/religation reaction of eukaryotic topoisomerase II: evidence for a nicked DNA intermediate.
Zechiedrich EL; Christiansen K; Andersen AH; Westergaard O; Osheroff N
Biochemistry; 1989 Jul; 28(15):6229-36. PubMed ID: 2551367
[TBL] [Abstract][Full Text] [Related]
11. Chromatin structure, not DNA sequence specificity, is the primary determinant of topoisomerase II sites of action in vivo.
Udvardy A; Schedl P
Mol Cell Biol; 1991 Oct; 11(10):4973-84. PubMed ID: 1656219
[TBL] [Abstract][Full Text] [Related]
12. Broken by the Cut: A Journey into the Role of Topoisomerase II in DNA Fragility.
Atkin ND; Raimer HM; Wang YH
Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31614754
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerase II-Induced Chromosome Breakage and Translocation Is Determined by Chromosome Architecture and Transcriptional Activity.
Canela A; Maman Y; Huang SN; Wutz G; Tang W; Zagnoli-Vieira G; Callen E; Wong N; Day A; Peters JM; Caldecott KW; Pommier Y; Nussenzweig A
Mol Cell; 2019 Jul; 75(2):252-266.e8. PubMed ID: 31202577
[TBL] [Abstract][Full Text] [Related]
14. Analysis of topoisomerase I and II cleavage sites on the Drosophila actin and Hsp70 heat shock genes.
Kroeger PE; Rowe TC
Biochemistry; 1992 Mar; 31(9):2492-501. PubMed ID: 1312349
[TBL] [Abstract][Full Text] [Related]
15. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
Marx G; Zhou H; Graves DE; Osheroff N
Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
[TBL] [Abstract][Full Text] [Related]
16. Batracylin (NSC 320846), a dual inhibitor of DNA topoisomerases I and II induces histone gamma-H2AX as a biomarker of DNA damage.
Rao VA; Agama K; Holbeck S; Pommier Y
Cancer Res; 2007 Oct; 67(20):9971-9. PubMed ID: 17942930
[TBL] [Abstract][Full Text] [Related]
17. Abasic sites stimulate double-stranded DNA cleavage mediated by topoisomerase II. DNA lesions as endogenous topoisomerase II poisons.
Kingma PS; Corbett AH; Burcham PC; Marnett LJ; Osheroff N
J Biol Chem; 1995 Sep; 270(37):21441-4. PubMed ID: 7665552
[TBL] [Abstract][Full Text] [Related]
18. Roles of nonhomologous end-joining pathways in surviving topoisomerase II-mediated DNA damage.
Malik M; Nitiss KC; Enriquez-Rios V; Nitiss JL
Mol Cancer Ther; 2006 Jun; 5(6):1405-14. PubMed ID: 16818498
[TBL] [Abstract][Full Text] [Related]
19. TDP2-dependent non-homologous end-joining protects against topoisomerase II-induced DNA breaks and genome instability in cells and in vivo.
Gómez-Herreros F; Romero-Granados R; Zeng Z; Alvarez-Quilón A; Quintero C; Ju L; Umans L; Vermeire L; Huylebroeck D; Caldecott KW; Cortés-Ledesma F
PLoS Genet; 2013; 9(3):e1003226. PubMed ID: 23505375
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes.
Wilstermann AM; Osheroff N
Curr Top Med Chem; 2003; 3(3):321-38. PubMed ID: 12570766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]